ArticleTherapeutic advances in hematology2021

The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma.

Joanna P MacEwan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.